Arcoma

Arcoma Gross Margin

The Gross Margin of Arcoma (ARCOMA.ST) as of Oct 23, 2026 is 5.24 %. In the previous year, Gross Margin was 39.93 % — a change of -86.86% (lower).

Gross Margin

5.24 %

YoY

-86.86%

Last updated:

Gross Margin of Arcoma is 2025 5.24 % . Gross Margin of Arcoma was 2024 39.93 % . It decreases by -86.86% lower compared to the previous year.

Arcoma's gross margin stands at 5.2%, down from 35.6% several years earlier.

The Arcoma Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
39.15 SEK
Jan 1, 2019
38.82 SEK
Jan 1, 2020
38.54 SEK
Jan 1, 2021
35.56 SEK
Jan 1, 2022
40.34 SEK
Jan 1, 2023
35.53 SEK
Jan 1, 2024
39.93 SEK
Jan 1, 2025
5.24 SEK
The Arcoma Gross Margin history
YEARGross MarginYoY
5.24 %-86.86%
39.93 %+12.39%
35.53 %-11.94%
40.34 %+13.46%
35.56 %-7.74%
38.54 %-0.74%
38.82 %-0.84%
39.15 %-2.28%
40.07 %-6.02%
42.63 %+5.07%
40.57 %-4.42%
42.45 %+10,054.30%
0.42 %+20.87%
0.35 %+39.92%
0.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Gross Margin of Arcoma is 5.24 % in 2025.

Gross Margin of Arcoma changed from 39.93 % to 5.24 %, representing a -86.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Arcoma since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Arcoma with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Arcoma

All Key Metrics — Arcoma